SCYNEXIS to Join H.C. Wainwright 26th Annual Global Investment Conference

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology firm dedicated to creating groundbreaking treatments for challenging and drug-resistant infections, has announced that its President and CEO, David Angulo, M.D., will present at the H. C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for Wednesday, September 11, 2024, at 10:00 AM ET in New York, NY. Dr. Angulo will also host individual meetings during the conference.

SCYNEXIS is recognized for pioneering innovative solutions in antifungal treatments, specifically to combat infections that are increasingly resistant to current drugs. The company's leading product is ibrexafungerp, which is part of their proprietary antifungal platform known as “fungerps.” This novel class of antifungal agents addresses a significant need in the medical community for more effective treatments against stubborn infections.

Ibrexafungerp has garnered significant milestones. The U.S. Food and Drug Administration (FDA) approved the drug's branded form, BREXAFEMME® (ibrexafungerp tablets), in June 2021 for the treatment of vulvovaginal candidiasis (VVC). Following this initial approval, a second indication was granted in November 2022, for reducing the recurrence of VVC. Other critical clinical investigations are underway, focusing on the drug's efficacy in treating life-threatening invasive fungal infections in hospitalized patients. 

SCYNEXIS is committed to advancing its antifungal portfolio with additional compounds at various stages of development. Among these is SCY-247, which is currently in the pre-clinical and discovery phases.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!